spacer
home > pmps > autumn 2009 > technology tackles counterfeiting
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Technology Tackles Counterfeiting

 

Counterfeiters are more active globally than ever before, feeding on consumer needs for cheaper products, with several distribution channels available to them. Are we doing enough to fight counterfeiting and are we using the right approach? Do we have systems capable of dealing with this issue? A novel technology which uses embedded intelligence in the packaging that cannot be duplicated, thereby creating unique IDs allows for the ultimate fight against counterfeiters. It is time for us to take advantage of this and empower the consumer to verify authenticity.

Drug counterfeiting inhibits growth of legitimate products in the marketplace. In the current global environment, counterfeits are growing significantly to occupy an astounding 10 per cent of the global drug marketplace, according to published reports by the World Health Organization (WHO). The problem is not associated with specific geographic regions, but hits every facet of our global supply chain. If published data on counterfeit vaccines is any indication, things could get even worse if consumers end up using counterfeit H1N1 vaccines and other products. The frightening aspect of all of this is the great reliance on trust alone, because the consumer or brand owner does not have the ability to verify the authenticity of the product any time, anywhere. The life sciences industry is a key target because of its high value products and weak or broken links in the supply chain – essentially the lack of endto- end supply chain visibility. The weak link in the supply chains within countries need to be fixed in order to enhance visibility in the global supply chain.

This article also examines the different options used as security features on packaging, and discusses if we are encouraging the adoption of the best approach with serialised IDs. The article also discusses the embedded, noncopiable intelligence in every package based on its structure, and asks if we would be better off using this as part of any standardised approach, especially as it costs much less than some of the technologies currently used.

STRENGTHENING BUSINESS PROCESSES

A recent study in the EU, Building Radio frequency Identification solutions for the Global Environment (BRIDGE), reported that full supply chain traceability of pharmaceutical products is entirely feasible in an open cross-border supply chain system, when using accepted standards.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Narendra Srivatsa is responsible for Cortegra’s packaging solutions and services for the healthcare industry. He has developed and launched the RxTrackNSecureTM brand to the pharmaceutical industry. Prior to joining Cortegra, he spent 15 years in a number of different key roles at International Paper, leading them into new products and markets. Narendra has been awarded numerous process and product patents, many of which have been commercialised or licensed. He has authored articles in many leading trade publications and has also developed and presented the training module on ‘RFID Enhanced Packaging’ as part of a day long training on ‘RFID in the Life Sciences’ presented at the Interphex 2005 and Interphex 2006.
spacer
Narendra Srivatsa
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI China opens with analysis pointing to a surge in growth in 2019

Shanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets – forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation.
More info >>

White Papers

Conveying Medical Guidance in Clinical Trials – A Survey

Europital Medical Consultancy

With the incremental demand for proactive safety surveillance throughout the conduct of clinical trials, the role of Medical Management is at the fore in ensuring the safety and wellbeing of the participants. The complex responsibilities of a Medical Monitor (MM) starts from the design and development phase, through to study close out. Understanding the principle behind the protocol and the prospective medical solution the study would deliver forms the bloodline for the MM role. Often, the MM is the face of contact for both the site personnel and the study team members with regard to medical, safety and scientific issues within the project. When it comes to medical guidance, the communication channel used to deliver solutions contributes to a large extent in effectively managing decisive situations. Our previous study on acquiring medical guidance from an operations team perspective revealed that e-mails were the most used communication method (see the article, 'Talking Points', in ICT November 2014). In our efforts to further strengthen the mode of medical guidance delivery, we designed a survey to study the existing trend and constraints in this communication chain management, as outlined here.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement